The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
Open accessAbstract
Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
WHO classification of tumours of soft tissue and bone
Fletcher, C. D. �. (2013) · Cited by 2,874
Ballo, M. T., Zagars, G. K., Pollack, A., Pisters, P. W. T., & Pollock, R. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.158 · Cited by 501
Self-citationSorafenib for Advanced and Refractory Desmoid Tumors
Gounder, M. M., Mahoney, M. R., Van Tine, B. A., Ravi, V., Attia, S., Deshpande, H. A., Gupta, A. A., Milhem, M. M., Conry, R. M., Movva, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805052 · Cited by 463
Self-citationKasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., Hohenberger, P., Penel, N., Messiou, C., van der Graaf, W. T., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx323 · Cited by 422
Self-citationSalas, S., Dufresne, A., Bui, B., Blay, J.-Y., Terrier, P., Ranchere-Vince, D., Bonvalot, S., Stoeckle, E., Guillou, L., Le Cesne, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5489 · Cited by 382
Self-citationFiore, M., Rimareix, F., Mariani, L., Domont, J., Collini, P., Le Péchoux, C., Casali, P. G., Le Cesne, A., Gronchi, A., & Bonvalot, S. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0586-2 · Cited by 374
Self-citationHigh‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004) · Cancer · doi:10.1002/cncr.11937 · Cited by 357
Desmoid Tumors: Clinical Features and Treatment Options for Advanced Disease
Kasper, B., Ströbel, P., & Hohenberger, P. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0281 · Cited by 336
Self-citationThe pharmacological treatment of aggressive fibromatosis: a systematic review
Janinis, J., Patriki, M., Vini, L., Aravantinos, G., & Whelan, J. S. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg064 · Cited by 297
Cited by
Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.006 · Cited by 1,115
Self-citationWhat’s new in musculoskeletal oncology
Errani, C., Mavrogenis, A. F., & Tsukamoto, S. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04590-1 · Cited by 11
Metadata
- Authors
- Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.-Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P. G., van Coevorden, F., Colombo, C., Dei Tos, A. P., Dileo, P., Ferrari, A., Fiore, M., Frezza, A. M., Garcia, J., Gladdy, R., Gounder, M., Gronchi, A., Haas, R., Hackett, S., Haller, F., Hohenberger, P., Husson, O., Jones, R. L., Judson, I., Kasper, B., Kawai, A., Kogosov, V., Lazar, A. J., Maki, R., Mathes, T., Messiou, C., Navid, F., Nishida, Y., Palassini, E., Penel, N., Pollock, R., Pieper, D., Portnoy, M., Raut, C. P., Roets, E., Sandrucci, S., Sbaraglia, M., Stacchiotti, S., Thornton, K. A., van der Graaf, W., van der Zande, K., van Houdt, W. J., Villalobos, V., Wagner, A. J., Wardelmann, E., Wartenberg, M., Watson, S., Weiss, A., & Zafiropoulos, N.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 127
- Pages
- 96-107
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W3004209283
- Cited by
- 506
- References
- 25
- FWCI
- 42.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.